The latest from Rhevera Medical.

Endologix Announces that Scott Ward Joins Board of Directors

Endologix announces the U. S. Centers for Medicare & Medicaid Services granted a Transitional Pass-Through (TPT) Payment for the DETOUR® System

Endologix to Present in Two Upcoming Healthcare Conferences.

Endologix Announces Results of Pooled Analysis of DETOUR1 and DETOUR2 Studies at 2023 VIVA Late-Breaking Clinical Trial Session

Endologix’s DETOUR^® System Earns Spot in Local and National Award Forums; Nominated for Prix Galien USA’s Best Medical Technology